Fungi: Sex and self defense

The fungus Aspergillus nidulans produces secondary metabolites during sexual development to protect itself from predators.
  1. Milton T Drott  Is a corresponding author
  1. Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, United States

When walking through the woods we often look up, focusing on the birds and the rustling leaves in the canopy above us, but on the ground a drama is unfolding: the fungi are under attack. Looking down you may see a slug grazing on mold that has established itself on an old log, or a mushroom swarmed by fruit flies on the forest floor. So how do fungi protect themselves from these attacks if they cannot physically escape?

Previous research has shown that fungi defend themselves using secondary metabolites, chemical compounds which are not essential for growth but involved in ecological interactions (Janzen, 1977; Rohlfs and Churchill, 2011). These compounds can be toxic to animals and/or drive them away from the fungus. As predators can appear without warning, fungi must be ready with the metabolites at short notice, either by making them ahead of time, or by rapidly creating them in response to a threat (Drott et al., 2017). However, even in the best-studied fungi, it is unclear exactly where and when these defensive chemicals are created, making it difficult to fully understand their ecological purpose.

Now, in eLife, researchers from the University of Göttingen – including Li Liu and corresponding authors Jennifer Gerke and Gerhard H Braus – report that a set of previously identified secondary metabolites called xanthones (Sanchez et al., 2011) are produced during certain life stages of the soil-dwelling fungus Aspergillus nidulans (Liu et al., 2021). Xanthones are synthesized through a series of chemical reactions controlled by a group of genes known as the mdp/xpt cluster. The proteins encoded by the mdp genes make the ‘backbone’ of the metabolite, which is then progressively modified by proteins produced from the xpt genes until the final compound is formed.

To narrow down where xanthones are synthesized in the fungus, Liu et al. added a fluorescent tag to the protein responsible for the final chemical reaction, as this represents the complete synthesis of the secondary metabolites produced by the mdp/xpt pathway. This revealed that xanthones are created in Hülle cells which support the development of cleistothecia, fruiting bodies that allow the fungus to sexually reproduce and last through the winter (Troppens et al., 2020). This suggests that xanthones are not produced throughout the life of the fungus, but are only generated during the stages of the fungus’ sexual lifecycle when cleistothecia form.

Next, Liu et al. set out to determine the role of other genes in the mdp/xpt cluster by creating a set of mutant fungi that are missing one of these genes. They found that each gene plays a specific role in the sequence of chemical reactions that synthesize the xanthones used by the fungi. As a result, none of the mutant strains were able to produce the final xanthones, and instead accumulated intermediate chemical structures that are generated during this pathway. Like xanthones, these intermediates only appeared at times when the fungus was forming cleistothecia.

It is clear from these findings that A. nidulans likely uses xanthones during sexual development; but what role do these secondary metabolites play in ecology? To investigate this, Liu et al. grew fungal colonies and cleistothecia from mutated and non-mutated (or wild-type) strains of A. nidulans and exposed them to arthropods (invertebrates with exoskeletons such as insects and arachnids) that eat fungi (Figure 1). Wild-type colonies – which can produce all of the xanthones – were damaged less heavily by the arthropods than the mutant colonies. Further experiments showed that, in addition to mitigating damage from arthropods, some of the intermediates formed during synthesis can suppress fungal growth when added to other fungi in the laboratory. However, these intermediates did not accumulate to high levels in the wild-type strain and also suppressed the development of A. nidulans, raising doubts about their potential benefit to the fungus when competing with other fungi in nature.

Chemical products of the mdp/xpt gene cluster protect A. nidulans from predators.

A. nidulans produces secondary metabolites called xanthones using a set of genes known as the mdp/xpt cluster. (Top) In the wild-type fungus, xanthones (shown as chemical structures) are produced by Hülle cells (small beige circles) and then accumulate in sexual fruiting bodies called cleistothecia (large black circles). When arthropods attack the wild-type fungus, the xanthones deter these predators and stop them from destroying the cleistothecia. (Bottom) Fungi with lab-induced mutations in the mdp/xpt genes are unable to produce xanthones, making them more susceptible to fungus-eating arthropods.

Image credit: Milton T Drott; Figure created using BioRender.com.

Hülle cells are found in other fungi (Dyer and O'Gorman, 2012), and genes resembling the mdp/xpt cluster occur in other species where no sexual cycle has been observed to date (de Vries et al., 2017). It remains to be seen how secondary metabolites that appear at specific life stages – like the ones in this study – translate into these other species. Furthermore, it is unclear how these chemical compounds relate to previous observations that other secondary metabolites with unknown functions are only produced under certain conditions (Georgianna et al., 2010). The findings of Liu et al. emphasize the complicated interplay between fungi and their environment, and spark further questions about about how the fungus' investment in protecting its sexual offspring has impacted its evolution.

References

Article and author information

Author details

  1. Milton T Drott

    Milton T Drott is in the Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, United States

    For correspondence
    mdrott@wisc.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9715-2200

Publication history

  1. Version of Record published:

Copyright

© 2021, Drott

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,349
    views
  • 101
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Milton T Drott
(2021)
Fungi: Sex and self defense
eLife 10:e73723.
https://doi.org/10.7554/eLife.73723

Further reading

    1. Biochemistry and Chemical Biology
    Bikash Adhikari, Katharina Schneider ... Elmar Wolf
    Research Article

    The development of proteolysis targeting chimeras (PROTACs), which induce the degradation of target proteins by bringing them into proximity with cellular E3 ubiquitin ligases, has revolutionized drug development. While the human genome encodes more than 600 different E3 ligases, current PROTACs use only a handful of them, drastically limiting their full potential. Furthermore, many PROTAC development campaigns fail because the selected E3 ligase candidates are unable to induce degradation of the particular target of interest. As more and more ligands for novel E3 ligases are discovered, the chemical effort to identify the best E3 ligase for a given target is exploding. Therefore, a genetic system to identify degradation-causing E3 ligases and suitable target/E3 ligase pairs is urgently needed. Here, we used the well-established dimerization of the FKBP12 protein and FRB domain by rapamycin to bring the target protein WDR5 into proximity with candidate E3 ligases. Strikingly, this rapamycin-induced proximity assay (RiPA) revealed that VHL, but not Cereblon, is able to induce WDR5 degradation - a finding previously made by PROTACs, demonstrating its predictive power. By optimizing the steric arrangement of all components and fusing the target protein with a minimal luciferase, RiPA can identify the ideal E3 for any target protein of interest in living cells, significantly reducing and focusing the chemical effort in the early stages of PROTAC development.

    1. Biochemistry and Chemical Biology
    2. Physics of Living Systems
    Debabrata Dey, Shir Marciano ... Gideon Schreiber
    Research Article

    For drugs to be active they have to reach their targets. Within cells this requires crossing the cell membrane, and then free diffusion, distribution, and availability. Here, we explored the in-cell diffusion rates and distribution of a series of small molecular fluorescent drugs, in comparison to proteins, by microscopy and fluorescence recovery after photobleaching (FRAP). While all proteins diffused freely, we found a strong correlation between pKa and the intracellular diffusion and distribution of small molecule drugs. Weakly basic, small-molecule drugs displayed lower fractional recovery after photobleaching and 10- to-20-fold slower diffusion rates in cells than in aqueous solutions. As, more than half of pharmaceutical drugs are weakly basic, they, are protonated in the cell cytoplasm. Protonation, facilitates the formation of membrane impermeable ionic form of the weak base small molecules. This results in ion trapping, further reducing diffusion rates of weakly basic small molecule drugs under macromolecular crowding conditions where other nonspecific interactions become more relevant and dominant. Our imaging studies showed that acidic organelles, particularly the lysosome, captured these molecules. Surprisingly, blocking lysosomal import only slightly increased diffusion rates and fractional recovery. Conversely, blocking protonation by N-acetylated analogues, greatly enhanced their diffusion and fractional recovery after FRAP. Based on these results, N-acetylation of small molecule drugs may improve the intracellular availability and distribution of weakly basic, small molecule drugs within cells.